UBR:NYE-ProShares Ultra MSCI Brazil Capped (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 18.6492

Change

+0.10 (+0.52)%

Market Cap

N/A

Volume

1.80K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

-0.86 (-4.14%)

USD 8.29B
QLD ProShares Ultra QQQ

-3.19 (-3.38%)

USD 6.07B
FNGU MicroSectors FANG+ Index 3X Le..

N/A

USD 5.57B
SSO ProShares Ultra S&P500

-1.80 (-2.12%)

USD 4.37B
UPRO ProShares UltraPro S&P500

-2.45 (-3.17%)

USD 3.08B
TECL Direxion Daily Technology Bull..

-3.00 (-4.48%)

USD 2.48B
YINN Direxion Daily FTSE China Bull..

-0.19 (-0.36%)

USD 1.91B
USD ProShares Ultra Semiconductors

-2.58 (-5.23%)

USD 0.82B
LABU Direxion Daily S&P Biotech Bul..

-5.89 (-7.35%)

USD 0.66B
UDOW ProShares UltraPro Dow30

-1.71 (-1.95%)

USD 0.59B

ETFs Containing UBR

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 35.34% 88% B+ 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 35.34% 88% B+ 98% N/A
Trailing 12 Months  
Capital Gain -33.22% 13% F 8% B-
Dividend Return 2.96% 90% A- 49% F
Total Return -30.27% 15% F 8% B-
Trailing 5 Years  
Capital Gain 19.09% 16% F 31% F
Dividend Return 7.77% 39% F 14% F
Total Return 26.85% 15% F 23% F
Average Annual (5 Year Horizon)  
Capital Gain 36.60% 63% D 90% A-
Dividend Return 37.34% 61% D- 90% A-
Total Return 0.73% 55% F 17% F
Risk Return Profile  
Volatility (Standard Deviation) 187.36% 21% F 5% F
Risk Adjusted Return 19.93% 37% F 35% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.